JAB-21822 is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Jian Li (1) and Allist Pharmaceuticals, Inc. (1). Registered phases: Phase 1 and Phase 2. Conditions studied include Colorectal Cancer; KRAS P.G12C; Pancreatic Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06008288 | A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation. (ClinicalTrials.gov ↗) KRAS P.G12C, Pancreatic Cancer, Solid Tumor |
Phase 2 | Recruiting |
| NCT06838338 | JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC Colorectal Cancer |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Colorectal Cancer | 1 |
| KRAS P.G12C | 1 |
| Pancreatic Cancer | 1 |
| Solid Tumor | 1 |
| Lead sponsor | Trials |
|---|---|
| Jian Li | 1 |
| Allist Pharmaceuticals, Inc. | 1 |
| Register | JAB-21822 trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how JAB-21822 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists JAB-21822 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.